Cargando…

Association of Endogenous Erythropoietin Levels and Iron Status With Cognitive Functioning in the General Population

BACKGROUND: Emerging data suggest that erythropoietin (EPO) promotes neural plasticity and that iron homeostasis is needed to maintain normal physiological brain function. Cognitive functioning could therefore be influenced by endogenous EPO levels and disturbances in iron status. OBJECTIVE: To dete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayerdem, Gizem, Bosma, Matthijs J., Vinke, Joanna Sophia J., Ziengs, Aaltje L., Potgieser, Adriaan R. E., Gansevoort, Ron T., Bakker, Stephan J. L., De Borst, Martin H., Eisenga, Michele F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024369/ https://www.ncbi.nlm.nih.gov/pubmed/35462689 http://dx.doi.org/10.3389/fnagi.2022.862856

Ejemplares similares

Iron deficiency, with and without anaemia, across strata of kidney function in kidney transplant recipients
por: Ayerdem, Gizem, et al.
Publicado: (2021)

Iron deficiency and cognitive functioning in kidney transplant recipients: findings of the TransplantLines biobank and cohort study
por: Vinke, Joanna Sophia J, et al.
Publicado: (2023)

Type of proton‐pump inhibitor and risk of iron deficiency in kidney transplant recipients – results from the TransplantLines Biobank and Cohort Study
por: Douwes, Rianne M., et al.
Publicado: (2021)

Iron deficiency after kidney transplantation
por: Vinke, Joanna Sophia J, et al.
Publicado: (2020)

Iron deficiency is related to lower muscle mass in community‐dwelling individuals and impairs myoblast proliferation
por: Vinke, Joanna Sophia J., et al.
Publicado: (2023)

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study
por: Eisenga, Michele F., et al.
Publicado: (2019)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

Erythropoietin in the General Population: Reference Ranges and Clinical, Biochemical and Genetic Correlates
por: Grote Beverborg, Niels, et al.
Publicado: (2015)

Long-term cognitive impairments in kidney transplant recipients: impact on participation and quality of life
por: Ziengs, Aaltje L, et al.
Publicado: (2022)

Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study
por: Byambasukh, Oyuntugs, et al.
Publicado: (2019)

Ferric carboxymaltose and SARS-CoV-2 vaccination-induced immunogenicity in kidney transplant recipients with iron deficiency: The COVAC-EFFECT randomized controlled trial
por: Vinke, Joanna Sophia J., et al.
Publicado: (2023)

Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: De Jong, Maarten A, et al.
Publicado: (2020)

Iron Deficiency and Nephrotoxic Heavy Metals: A Dangerous Interplay?
por: Rawee, Pien, et al.
Publicado: (2023)

Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus
por: Vinke, Joanna Sophia J., et al.
Publicado: (2019)

Decreased haemoglobin levels are associated with lower muscle mass and strength in kidney transplant recipients
por: Vinke, Joanna Sophia J., et al.
Publicado: (2022)

Effect of intravenous iron on endogenous erythropoietin and FGF-23 secretion in patients with chronic kidney disease
por: Muras-Szwedziak, Katarzyna, et al.
Publicado: (2023)

Sex and N-terminal pro B-type natriuretic peptide: The potential mediating role of iron biomarkers
por: Khatami, Farnaz, et al.
Publicado: (2022)

Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
por: Eisenga, Michele F., et al.
Publicado: (2018)

Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population
por: Kieneker, Lyanne M., et al.
Publicado: (2017)

Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND
por: van der Leeuw, Joep, et al.
Publicado: (2020)

Endogenous erythropoietin at birth is associated with neurodevelopmental morbidity in early childhood
por: Rancken, Elina J., et al.
Publicado: (2021)

Muscle mass determined from urinary creatinine excretion rate, and muscle performance in renal transplant recipients
por: Stam, Suzanne P., et al.
Publicado: (2019)

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort
por: Yeung, Stanley M. H., et al.
Publicado: (2021)

Differentiation of endogenous erythropoietin and exogenous ESAs by Western blotting
por: Yasuoka, Yukiko, et al.
Publicado: (2020)

Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General Population
por: Taylor, Jacob M., et al.
Publicado: (2016)

Fibroblast growth factor 23 mediates the association between iron deficiency and mortality in worsening heart failure
por: van der Wal, Haye H., et al.
Publicado: (2020)

Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx): rationale and study protocol for a double-blind, randomised, placebo-controlled trial
por: Vinke, Joanna SJ, et al.
Publicado: (2023)

Changes in Iron Status Biomarkers with Advancing Age According to Sex and Menopause: A Population-Based Study
por: Merlo, Francesco, et al.
Publicado: (2023)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
por: Hofman, Jesse M. G., et al.
Publicado: (2018)

Digital arterial pressure pulse wave analysis and cardiovascular events in the general population: the Prevention of Renal and Vascular End-stage Disease study
por: De Jong, Maarten A., et al.
Publicado: (2020)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Fasting Ketone Bodies and Incident Type 2 Diabetes in the General Population
por: Szili-Torok, Tamas, et al.
Publicado: (2023)

EV-3, an endogenous human erythropoietin isoform with distinct functional relevance
por: Bonnas, Christel, et al.
Publicado: (2017)

A novel technique to treat acquired Chiari I malformation after supratentorial shunting
por: Potgieser, Adriaan R. E., et al.
Publicado: (2016)

Management of anaemia in CKD—the relative importance of erythropoietin and iron
por: Agarwal, Rajiv
Publicado: (2011)

Sodium–Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?
por: Post, Adrian, et al.
Publicado: (2020)

Iron Deficiency Defined by Hepcidin in Critically Ill Patients
por: Eisenga, Michele F.
Publicado: (2021)

Visuomotor Dissociation in Cerebral Scaling of Size
por: Potgieser, Adriaan R. E., et al.
Publicado: (2016)

Elevated Endogenous Erythropoietin Concentrations Are Associated with Increased Risk of Brain Damage in Extremely Preterm Neonates
por: Korzeniewski, Steven J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nm6h2mts5lkfsj2qu3vi4jluht